Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
—
—
—
Zenlabs Ethica, formerly Neelkanth Technologies Limited, is a pharmaceutical company engaged in trading/marketing in pharmaceutical products
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
Zenlabs Ethica Ltd - 530697 - Non-Applicability Of Disclosure Of Related Party Transactions For The Half Year Ended On 30Th September, 2024 | Download
Zenlabs Ethica Ltd - 530697 - Non-Applicability Of Disclosure Of Related Party Transactions For The Half Year Ended On 30Th September, 2024 | Download
Interim • Div/Share: ₹ 0.25
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant